Ensayos clínicos

Inclusion Criteria:

• An established liver disease patient seen in the Division of Gastroenterology and Hepatology. 
• Patients must be currently taking at least 5 prescribed medications.
• An established Mayo Clinic patient within a Division of Gastroenterology and Hepatology.   (Gastroenterology and Hepatology is piloting PGx testing with the Center for Individualized Medicine, seeking clinical information from emerging PGx testing technologies available in CLIA/CAP laboratories.)
• Patient is age 18 or above.
• Patients must understand and provide written informed consent and HIPAA authorization prior to initiation of any study-specific procedures.
• Patient is willing to engage in a medication assessment as part of their clinical visit preparation (when needed).

Exclusion Criteria: 

• Patient with uncontrolled concurrent illness including psychiatric illness, or situations that would limit compliance with the study requirements or the ability to willingly give written informed consent.